Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-10 Purchase |
2022-03-14 5:38 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
226,000 | $0.67233 | $151,946 | 47,988,442 (Indirect Direct) |
View |
| 2022-03-03 Purchase |
2022-03-07 6:09 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
510,000 | $0.67477 | $344,133 | 47,762,442 (Indirect Direct) |
View |
| 2022-02-24 Purchase |
2022-02-28 5:53 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
140,000 | $0.79861 | $111,806 | 47,252,442 (Indirect Direct) |
View |
| 2022-02-17 Purchase |
2022-02-22 6:37 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
288,000 | $0.80404 | $231,564 | 47,112,442 (Indirect Direct) |
View |
| 2022-01-18 Purchase |
2022-01-20 6:14 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
312,000 | $0.87976 | $274,486 | 46,824,442 (Indirect Direct) |
View |
| 2022-01-12 Purchase |
2022-01-14 5:49 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
455,000 | $0.99509 | $452,768 | 46,512,442 (Indirect Direct) |
View |
| 2022-01-07 Purchase |
2022-01-11 6:18 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
645,000 | $0.99679 | $642,931 | 46,057,442 (Indirect Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 6:19 pm |
Avalo Therapeutics Inc. | AVTX | Wilkins H Jeffrey Chief Medical Officer |
6,371 | $1.57 | $10,002 | 33,373 (Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:17 pm |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Accounting Officer |
955 | $1.57 | $1,499 | 9,004 (Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:16 pm |
Avalo Therapeutics Inc. | AVTX | Harrell James Archie Jr Chief Commercial Officer |
1,093 | $1.57 | $1,716 | 36,766 (Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:15 pm |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Scientific Officer |
4,267 | $1.57 | $6,699 | 85,639 (Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:13 pm |
Avalo Therapeutics Inc. | AVTX | Greenway Schond L. CFO |
2,231 | $1.57 | $3,503 | 3,883 (Direct) |
View |
| 2021-09-15 Purchase |
2021-09-17 2:25 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
5,700,000 | $2.2031 | $12,557,902 | 45,412,442 (Indirect Direct) |
View |
| 2021-08-16 Purchase |
2021-08-18 5:54 pm |
Cerecor Inc. | CERC | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
50,000 | $2.7638 | $138,188 | 39,712,442 (Indirect Direct) |
View |
| 2021-08-04 Purchase |
2021-08-06 3:15 pm |
Cerecor Inc. | CERC | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
150,000 | $2.7234 | $408,515 | 39,662,442 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-31 Option Award |
2022-04-04 5:13 pm |
2022-03-31 2032-03-31 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
2,985 | $0 | 2,985 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-10 5:50 pm |
N/A 2032-03-08 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-10 5:38 pm |
N/A 2032-03-08 |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 4:19 pm |
N/A 2032-01-04 |
Avalo Therapeutics Inc. | AVTX | Smolinski Stephen Chief Commercial Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:28 pm |
2021-12-31 2031-12-31 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
737 | $0 | 737 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:26 pm |
2021-12-31 2031-12-31 |
Avalo Therapeutics Inc. | AVTX | Persson Magnus Director |
7,943 | $0 | 7,943 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:25 pm |
2021-12-31 2031-12-31 |
Avalo Therapeutics Inc. | AVTX | Miller Joseph M Director |
8,920 | $0 | 8,920 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:23 pm |
2021-12-31 2031-12-31 |
Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director |
12,767 | $0 | 12,767 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-03 8:44 pm |
N/A 2031-12-01 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-11-10 Option Award |
2021-11-12 4:18 pm |
N/A 2031-11-10 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:48 pm |
2021-09-30 2031-09-30 |
Avalo Therapeutics Inc. | AVTX | Bruhn Suzanne Louise Director |
5,204 | $0 | 5,204 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:45 pm |
2021-09-30 2031-09-30 |
Avalo Therapeutics Inc. | AVTX | Gutry Phil Director |
4,718 | $0 | 4,718 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:42 pm |
2021-09-30 2031-09-30 |
Avalo Therapeutics Inc. | AVTX | Miller Joseph M Director |
6,939 | $0 | 6,939 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:38 pm |
2021-09-30 2031-09-30 |
Avalo Therapeutics Inc. | AVTX | Persson Magnus Director |
5,985 | $0 | 5,985 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:33 pm |
2021-09-30 2031-09-30 |
Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director |
9,541 | $0 | 9,541 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 4:28 pm |
2021-10-01 2031-10-01 |
Avalo Therapeutics Inc. | AVTX | COLA MICHAEL F Chief Executive Officer |
78,116 | $0 | 78,116 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 4:44 pm |
2021-07-01 2031-07-01 |
Cerecor Inc. | CERC | COLA MICHAEL F Chief Executive Officer |
51,740 | $0 | 51,740 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:18 pm |
2021-06-30 2031-06-30 |
Cerecor Inc. | CERC | Bruhn Suzanne Louise Director |
3,465 | $0 | 3,465 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:14 pm |
2021-06-30 2031-06-30 |
Cerecor Inc. | CERC | KAPLAN GILLA Director |
6,353 | $0 | 6,353 (Direct) |
View |